Salva, Kim Bailey F.
HRN: 26-93-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/08/2025
04/15/2025
IV
45mg
Q6h
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes